CRP and COVID-19: In addition, COVID‐19 patients with elevated NLR, CRP, and SII levels should be vigilant for concurrent SSNHL, and appropriate measures, such as anti‐inflammatory treatment, should be implemented to facilitate early intervention and reduce disability rates.